Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Invasive Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableUnknownNCT05951699
What this trial is testing

Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 105
Testing effectiveness (Phase 2)Ended earlyNCT01891357
What this trial is testing

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

Who this might be right for
Carcinoma, Ductal, Breast
Women's Cancer Study Group GmbH 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT01334021
What this trial is testing

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
M.D. Anderson Cancer Center 1,100
Not applicableLooking for participantsNCT07658170
What this trial is testing

Evaluation of the Efficacy and Safety of Using Platelet-rich Fibrin (PRF)-Based Lipobolus for the Immediate Reconstruction of Defects After Breast-conserving Resection for Breast Cancer (Minimally Invasive Primary Immediate Grafting)

Who this might be right for
Breast CancerLipofillingFat Graft+1 more
The Leningrad Regional Clinical Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00944047
What this trial is testing

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

Who this might be right for
Breast Cancer
University of Kansas Medical Center 32
Testing effectiveness (Phase 2)Ended earlyNCT00148720
What this trial is testing

Capecitabine in Women With Operable Breast Cancer

Who this might be right for
Invasive Breast CarcinomaPrimary Invasive Breast CancerStage I Breast Cancer+2 more
Dana-Farber Cancer Institute 80
Not applicableStudy completedNCT01015625
What this trial is testing

Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer

Who this might be right for
Synchronous Metastasized Breast CancerCirculating Tumor Cells
Austrian Breast & Colorectal Cancer Study Group 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107
What this trial is testing

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Who this might be right for
Breast CarcinomaBreast LumpEdema+8 more
M.D. Anderson Cancer Center 42
Not applicableEnded earlyNCT04016935
What this trial is testing

EndoPredict® Extended Endocrine Trial (EXET)

Who this might be right for
Primary Invasive Breast Cancer
Myriad Genetic Laboratories, Inc. 855
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Large-scale testing (Phase 3)UnknownNCT01204801
What this trial is testing

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Who this might be right for
Breast Cancer
Medifocus, Inc. 238
Not applicableNot Yet RecruitingNCT07676344
What this trial is testing

CRYO-TOUCH: Cryoablation of the Primary Breast Tumor in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hospices Civils de Lyon 42
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)UnknownNCT03417622
What this trial is testing

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Who this might be right for
Breast Cancer
Mansoura University 370
Early research (Phase 1)Study completedNCT03980509
What this trial is testing

A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors

Who this might be right for
Breast Cancer
Medical University of South Carolina 22
Testing effectiveness (Phase 2)Ended earlyNCT01220128
What this trial is testing

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 66
Not applicableActive Not RecruitingNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Next Page